Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23554
Full metadata record
DC FieldValueLanguage
dc.contributor.authorArmand, Philippe-
dc.contributor.authorMurawski, Niels-
dc.contributor.authorMolin, Daniel-
dc.contributor.authorZain, Jasmine-
dc.contributor.authorEichhorst, Barbara-
dc.contributor.authorGulbas, Zafer-
dc.contributor.authorHawkes, Eliza A-
dc.contributor.authorPagel, John M-
dc.contributor.authorPhillips, Tycel-
dc.contributor.authorRibrag, Vincent-
dc.contributor.authorSvoboda, Jakub-
dc.contributor.authorStathis, Anastasios-
dc.contributor.authorChatterjee, Arkendu-
dc.contributor.authorOrlowski, Robert-
dc.contributor.authorMarinello, Patricia-
dc.contributor.authorChristian, Beth-
dc.date2020-07-
dc.date.accessioned2020-06-18T00:24:57Z-
dc.date.available2020-06-18T00:24:57Z-
dc.date.issued2020-06-16-
dc.identifier.citationBritish Journal of Haematology 2020; 190(2): e117-e120en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/23554-
dc.language.isoeng-
dc.subjectPD-1en
dc.subjectRichter syndromeen
dc.subjectchronic lymphocytic leukaemiaen
dc.subjectimmunotherapyen
dc.subjectpembrolizumaben
dc.titlePembrolizumab in relapsed or refractory Richter syndrome.en
dc.typeJournal Articleen
dc.identifier.journaltitleBritish Journal of Haematologyen
dc.identifier.affiliationOncology Institute of Southern Switzerland, Bellinzona, Switzerlanden
dc.identifier.affiliationDana-Farber Cancer Institute, Boston, MA, USAen
dc.identifier.affiliationMerck & Co., Inc, Kenilworth, NJ, USAen
dc.identifier.affiliationCity of Hope, Duarte, CA, USAen
dc.identifier.affiliationSwedish Center for Blood Disorders and Stem Cell Transplants, Swedish Cancer Institute, Seattle, WA, USAen
dc.identifier.affiliationUniversity of Cologne, Cologne, Germanyen
dc.identifier.affiliationRogel Cancer Center, Ann Arbor, MI, USAen
dc.identifier.affiliationThe James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, OH, USAen
dc.identifier.affiliationPerelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USAen
dc.identifier.affiliationAnadolu Medical Center, Istanbul, Turkeyen
dc.identifier.affiliationUniversitäts-klinikum des Saarlandes Innere Medizin I, Homburg, Germanyen
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationExperimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden..en
dc.identifier.affiliationInstitut Gustave Roussy, Villejuif, Franceen
dc.identifier.doi10.1111/bjh.16762en
dc.type.contentTexten
dc.identifier.orcid0000-0001-6098-1603en
dc.identifier.orcid0000-0002-0376-2559en
dc.identifier.orcid0000-0003-2143-9672en
dc.identifier.orcid0000-0002-5221-353Xen
dc.identifier.pubmedid32544980-
dc.type.austinLetter-
local.name.researcherHawkes, Eliza A
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

20
checked on Oct 5, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.